Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Super-Scope for eyes: imaging trial spots hidden clues in blindness

NCT ID NCT04129021

Knowledge-focused Sponsor: Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a high-resolution imaging system to see tiny structures in the eye that routine tools cannot detect. Researchers will scan 1,200 people with various eye conditions and healthy volunteers. The goal is to better understand diseases like glaucoma, diabetes, and retinal degeneration.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could improve how doctors see and understand eye diseases, leading to earlier or more accurate diagnoses.
What could go wrong
This is an observational imaging study, not a treatment trial. It may not directly change patient care or outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 1,200 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jul 2019

Expected to finish

Jul 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * People over 18 * Patient with a pathology affecting the eye or healthy volunteer * Participant who signed the consent * Beneficiaries of the health insurance Exclusion Criteria: * Patients with a history of photosensitivity. * Patients who have just received a photodynamic therapy treatment ( * Patients taking drugs with photosensitivity as a side effect. * Persons with pacemakers or other implanted electronic medical device * Patients with viral conjunctivitis or any other infectious disease. * Patients with skin lesions on the neck or forehead * Patients at high risk of damage from optical radiation, such as aphakic patients, or patients with decreased sensitivity to light due to fundus disease. * Pregnant or lactating women * Participant unable to be followed throughout the study * Vulnerable people * Subjects with predisposition to closure of the iridocorneal angle

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Corneal dystrophy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

age-related macular degeneration corneal dystrophy diabetes mellitus dry eye syndrome glaucoma hereditary macular dystrophy hypertensive disorder injury keratoconus macular degeneration Macular Edema macular retinal edema retinal degeneration retinal detachment retinitis pigmentosa stroke disorder vasculitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Corneal dystrophy Diabetes Dry eye Glaucoma Hypertension Keratoconus Macular dystrophy Macular edema Maculopathy, age related Retinal degeneration Retinal detachment Retinitis pigmentosa Stroke Trauma Vascular inflammation

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts

    RECRUITING

    Paris, 75012, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.